The Latest
-
Device firms back latest MDUFA deal, while patients want more postmarket safety
The latest agreement includes higher fees for overseas firms, hiring transparency requirements and greater use of real-world evidence.
-
IRhythm grows heart monitoring leadership with $288M VitalConnect buy
Acquiring VitalConnect could unlock a $1 billion cardiac monitoring market that is only partly served by iRhythm’s existing devices.
-
Q&A
When does it make sense to build software instead of buy? One health system’s answer.
NYU Langone Health and Dana-Farber Cancer Institute built an oncology decision support tool to guide clinicians through treatment. Now, the institutions are commercializing the product so other health systems can use it too.
-
FDA sets advisory panel for Galleri multicancer screening test
Outside experts will convene in September to review Grail’s premarket approval application for the MCED blood test. Experts selected for the committee will be key to watch, an analyst said.
-
Medtronic gets CE mark for ablation to treat ventricular tachycardia
Older ablation approaches for ventricular tachycardia have been suboptimal, Medtronic said. The company plans to bring a more effective treatment for the life-threatening heart condition.
-
Philips forms 6 patient monitoring partnerships
By employing wearable devices to support patient monitoring between the hospital and home, Philips hopes to improve care continuity.
-
Q&A
Medtronic on the future of AI-assisted surgery
Medtronic’s George Murgatroyd says an advanced computing platform that works with the company’s Hugo robot will power AI algorithms that can assist surgeons as they operate.
-
Zimmer Biomet sales force revamp going better than expected, CEO says
The restructuring, intended to give Zimmer Biomet a fully dedicated sales force, is expected to be complete by the end of 2027.
-
BD recalls intraosseous needle sets associated with 4 deaths
Some needles were manufactured with incorrect dimensions, making it difficult to remove the stylet after placement.
-
Solventum plans software separation to become ‘true medtech company’
The software business needs “a different investment level” to quickly realize its potential, Solventum’s CEO said.
-
STAAR Surgical appoints Warren Foust as permanent CEO
The implantable eye lens company began searching for a new CEO shortly after its sale to Alcon collapsed in January.
-
Caristo wins FDA authorization for cardiovascular risk predictor
The University of Oxford spinout will soon launch the AI tool, which research suggests could help assess heart attack risk in patients who don’t have obstructive coronary artery disease.
-
Danaher promotes Julie Sawyer Montgomery to CEO
The executive has led Danaher’s diagnostics business, where she helped triple operating profit during her tenure and oversaw the recent acquisition of Masimo.
-
DeepHealth gets FDA nod for AI tool that reads ultrasounds, creates reports
DeepHealth’s tool automates lesion detection, characterization and reporting from breast ultrasound scans.
-
Retrieved from Integer Holdings on August 03, 2026
KKR to take Integer private for $5.7B
Integer expects to gain flexibility and capital to invest in its contract development and manufacturing business under KKR.
-
Medicare finalizes 2.3% hospital inpatient pay raise for 2027
Regulators also finalized the first nationwide, mandatory payment model to reduce the cost of joint replacements starting in 2028. Hospitals said the pay raise was inadequate, and chafed at the mandatory nature of the new model.
-
Henry Schein removes 3 longtime execs in leadership shakeup
The reorganization comes months after Fred Lowery was named CEO and the company deepened its relationship with private equity firm KKR.
-
Siemens Healthineers names new head of the Americas
The company disclosed the appointment of João Seabra the day before cutting its full-year sales outlook in response to continued challenges at its diagnostics division.
-
MMI to expand study of robotic microsurgery for Alzheimer’s
The FDA is allowing MMI to enroll more patients in a feasibility trial studying use of the Symani robot for microsurgery to restore drainage paths in the lymph nodes of Alzheimer's patients.
-
Stryker catching up on orders, manufacturing after cyberattack
CEO Kevin Lobo said the company is working through a backlog of orders and grappling with a supply disruption related to Inari Medical.
-
Q&A
What J&J’s Ottava robot brings to the surgical table
Rocco De Bernardis, global president for Ottava, gets into the details of what makes the new robotic surgery system different from the competition and how the healthcare giant plans to roll it out.
-
Siemens Healthineers, Cleveland Clinic form 10-year alliance
The deal to provide a range of imaging and therapeutic technologies to Cleveland Clinic extends the partners’ longtime relationship and follows a recent 10-year pact between Siemens Healthineers and Mayo Clinic.
-
Boston Scientific again cuts 2026 guidance
Challenges in the electrophysiology and Watchman businesses led the medtech company to cut its sales and earnings per share forecasts for the second quarter in a row.
-
Medtronic leads $37M investment in ablation mapping startup CoreMap
Medtronic has backed CoreMap to address a critical unmet need in atrial fibrillation treatment.
-
FTC sues Hims & Hers over alleged privacy violations, deceptive billing practices
Regulators say the telehealth company illegally shared patient health data with advertisers and misled its customers. Hims & Hers hit back, calling the claims “baseless.”